A Boston based holding company, established for the purpose of investing into a portfolio of North American healthcare companies, to create capabilities necessary for an Integrative Disease Management Platform focused primarily on Metabolic and Chronic Diseases.

SD Medica attempts to cross fertilize each portfolio company’s offering with a complementary sister portfolio-company, striving for a more powerful value proposition and enhanced revenue stream. Its objective is to deploy the state-of-the art in technology, m/health, personalized medicine and best practices in health services as solutions for the patients, providers and payers. SDM works closely with a host of academic, healthcare and investment banking strategic partners in tandem with governments and health authorities in expanding the global reach of such North American based healthcare and technology firms, while responding to Regional challenges and health issues in the Middle East. In doing so it enters into several unique licensing or distribution arrangements with healthcare focused businesses in the GCC Region in order to help solve the diabetes, obesity and chronic conditions and related life style management issues.

A combination of roll-up strategy, minority or majority ownership and licensing strategy combining existing revenue generating companies and venture stage companies establishes the platform; investment strategy is synergistic and accretive, whereby each company on their own could justify a return on invested capital; collectively and well cross-fertilized, they could do even better. The resultant integrated healthcare platform should have a rich holistic value proposition for the payer, provider and patient. Our strategic partners include an alliance of top medical universities and teaching hospitals, target domain experts and scholars and thought leaders in healthcare, education and policy.

We have identified portfolio companies and certain capabilities to bridge the U.S. healthcare innovations with the knowledge economy of the GCC Region.

Back to Portfolio

Silicon Kinetics was founded in April 2002 in San Diego, California, as a spin-off from Trex Enterprises Corporation, an advanced R&D house, with core competencies in optoelectronics, materials and systems engineering. Silicon Kinetics is headquartered in San Diego, with tools and nanoporous silicon development and manufacturing facilities.

Silicon Kinetics developed the world’s first 3D biosensor surface for label-free biomolecular interaction analysis at superior sensitivity. Silicon Kinetics SKi Pro® platform was launched at the PEGS conference in April 2009 in Boston, Massachussetts. Silicon Kinetics SKi Bridge® interface to mass spectrometry was launched in 2011.

Silicon Kinetics (SKI) is the first company to develop and deploy affinity capture systems that operate in line with mass spectrometers (AC-MS) to produce more efficient screening tools for drug development applications. Amgen and SAIC are among the early validating buyers of SKI technology. For more than a decade, the competition has sought to develop a reliable and consistent AC-MS system; they have not succeeded. Although SKI’s initial sales have been purchased for drug development research, extending the SKI technology into diagnostic and other high usage applications should enable the company to achieve exponential growth in sales. SKI has targeted diabetes diagnosis and tracking in the GCC Region of the Middle East as the first such high usage application. Our future plans include further clinical and diagnostics applications as well as food safety testing (ongoing detection of pathogens and contaminants).

SKI has also successfully licensed the application of its technology for use in protecting pharmaceutical and nutriceutical companies against drug counterfeiting. The same technology that allows us to detect low abundance biomolecules allows us to create unique tags on each pill with silicon, which is a GRAS (generally recognized as safe) material by the US Food and Drug Administration. TruTag has recently announced a major investment from a leading Chinese packaging company that we believe will presage the market development of its product offering. The Company’s technology has won it a series of awards, most recently as a Technology Pioneer at the World Economic Forum and as a recipient of the prestigious Gold Edison award (see http://www.trutags.com/2009/trutag-technologies-wins-gold-edison-awards-2014/). Royalties from Trutag could scale substantially if TruTags reaches its business plan goals.

http://www.siliconkinetics.com/

Back to Portfolio

CrossFiber’s unique combination of performance and cost makes LiteSwitch™ systems the most suitable across all major applications in data centers and telco fiber optic switching. The Company has strategic partners and Tier 1 customers enabling them with novel architectures in data centers and next-generation fiber optic telco networks. It has re-invented every element of photonic switching, until it shrank size, packed performance and eliminated costly technologies.

Fueled by the services provided by leading companies, cloud computing networks are expanding at a cumulative growth rate of 69%/yr. These companies are building and operating data centers with very large numbers of host computers and storage appliances. These devices, which in the largest data centers total in the hundreds of thousands, must be interconnected with high-speed communications networks. Traditional optoelectronic technology is increasingly insufficient for providing cost-effective connectivity at the link transmission speeds required. CrossFiber provides all-optical link speed agnostic communications technology that will enable the continued growth and performance of next-generation cloud computing networks. Total addressable market for CrossFiber’s technology over the next five to seven years is in excess of $5B.

http://www.crossfiber.com/

Back to Portfolio

Auterra has developed a patented oil de-sulfurization and upgrading technology – the FlexUP™ oil upgrading process. Auterra’s oil desulfurization process creates a paradigm shift in the chemistry used to remove sulfur during the oil refining process. With recent performance gains, the FlexUP process is offering the oil industry net value propositions that are in the dollars per barrel range. This level of performance and the novelty of the FlexUP process are driving interest from major global oil and energy companies.

Auterra’s proprietary process, FlexUP™, enables producers and refiners to improve the quality of their oil and oil products by removing pollutants and increasing API gravity. With both upstream and downstream applications, FlexUP™ is a low-cost, low-energy process that minimizes Carbon Dioxide emissions while maximizing oil value.

Reducing sulfur content in petroleum and coal-derived fuels remains critical to mitigating air pollution from transportation exhaust on a global basis. The urgency of this challenge is heightened by the fact that the concentration of sulfur continues to grow in petroleum supplies while regulatory standards are growing ever more stringent. Presently, the refining industry employs hydrodesulfurization (HDS) to remove sulfur compounds. This process is energy intensive, expensive and produces 25% of a refinery’s carbon output.

As sulfur regulations reach into the heavier products (marine fuel, fuel oil, etc.) hydrotreating becomes less efficient and consequently must be run at higher temperatures and pressures which increase a refinery’s CO2 footprint.

Compounding the challenges associated with these sulfur reducing regulations is the fact that crude oil is becoming heavier and more sour. Consequently, the energy required to meet environmental regulations will become exponentially more expensive and has created a regulatory paradox: sulfur levels cannot be reduced without increasing CO2 emissions.

Additionally, price differentials between light-sweet crudes and heavy-sour crudes will continue to expand as refiners discount for contaminants such as high sulfur, high TAN and low API gravity. Consequently, alternative desulfurization and upgrading technologies remain an industry priority.

http://www.auterrainc.com/

Back to Portfolio